In 2020, the market value of insulin pharmaceutical products in India amounted to approximately 376 million U.S. dollars. Insulin constitutes 65% of the insulin and biosimilars market in India owing to the country’s large diabetic population.
…. more: Statista.com (Quelle/Source)